E-LIB Suche - Ergebnisse für: Boccadoro, Mario

1

Additional copies of 1q negatively impact the outcome of mu..:

D'Agostino, Mattia ; Rota-Scalabrini, Delia ; Belotti, Angelo...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Belantamab mafodotin in triple‐refractory multiple myeloma ..:

Fazio, Francesca ; Petrucci, Maria Teresa ; Corvatta, Laura...
eJHaem. 5 (2024) 3 - p. 485-493 , 2024

Link: https://doi.org/10.1002/..

3

Management of patients with multiple myeloma and COVID-19 i..:

Terpos, Evangelos ; Musto, Pellegrino ; Engelhardt, Monika...
Leukemia. 37 (2023) 6 - p. 1175-1185 , 2023

Link: https://doi.org/10.1038/..

4

Rates of Influenza and Pneumococcal Vaccination and Correla..:

Thompson, Michael A. ; Boccadoro, Mario ; Leleu, Xavier...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 3 - p. e171-e181 , 2023

Link: https://doi.org/10.1016/..

5

P-303 Belantamab mafodotin in patients with relapsed/refrac..:

Offidani, Massimo ; Morè, Sonia ; Cavo, Michele...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S205 , 2023

Link: https://doi.org/10.1016/..

6

Impact of minimal residual disease standardised assessment ..:

Zamagni, Elena ; Oliva, Stefania ; Gay, Francesca...
eClinicalMedicine. 60 (2023) - p. 102017 , 2023

Link: https://doi.org/10.1016/..

7

P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD)..:

Montefusco, Vittorio ; Maria Cafro, Anna ; Margiotta-Casaluci, Gloria...
HemaSphere. 7 (2023) S3 - p. e729785d , 2023

Link: https://doi.org/10.1097/..

8

Predictors of early morbidity and mortality in newly diagno..:

Mai, Elias K. ; Hielscher, Thomas ; Bertsch, Uta...
Leukemia. 38 (2023) 3 - p. 640-647 , 2023

Link: https://doi.org/10.1038/..

9

Prevention and management of adverse events during treatmen..:

Ludwig, Heinz ; Terpos, Evangelos ; van de Donk, Niels...
The Lancet Oncology. 24 (2023) 6 - p. e255-e269 , 2023

Link: https://doi.org/10.1016/..

10

A prospective, multicenter study on hematopoietic stem-cell..:

Mina, Roberto ; Petrucci, Maria Teresa ; Bonello, Francesca...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

11

P804: PLASMA CELL LEUKEMIA-LIKE TRANSCRIPTOME OF BONE MARRO..:

D'agostino, Mattia ; Bruinink, Davine Hofste Op ; van Duin, Mark...
HemaSphere. 7 (2023) S3 - p. e36094ab , 2023

Link: https://doi.org/10.1097/..

12

P-323 A Phase 3 randomized, open-label trial of selinexor, ..:

Weisel, Katja ; Bentur, Ohad ; Van Domelen, Dane..
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S216-S217 , 2023

Link: https://doi.org/10.1016/..

13

Carfilzomib induction, consolidation, and maintenance with ..:

Mina, Roberto ; Musto, Pellegrino ; Rota-Scalabrini, Delia...
The Lancet Oncology. 24 (2023) 1 - p. 64-76 , 2023

Link: https://doi.org/10.1016/..

14

P-109 Carfilzomib-lenalidomide-dexamethasone Vs. lenalidomi..:

D'Agostino, Mattia ; Antonioli, Elisabetta ; Gamberi, Barbara...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S94-S95 , 2023

Link: https://doi.org/10.1016/..

15

Prospective evaluation of minimal residual disease in the p..:

Oliva, Stefania ; Genuardi, Elisa ; Paris, Laura...
eClinicalMedicine. 60 (2023) - p. 102016 , 2023

Link: https://doi.org/10.1016/..